4Dx Limited is a medical technology company established to commercialize four-dimensional lung imaging technology. XV Technology™ provides a state-of-the-art, non-invasive way of understanding regional lung motion and airflow in real-time within the breathing lungs. This enables highly detailed maps of patterns of lung motion and pulmonary function, with functional deficits detected through local differences in movement. The end result: improving millions of lives through earlier disease detection and more accurate monitoring of chronic respiratory conditions.
ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials. For nearly 50 years ERT has been balancing the knowledge of what works with a vision for what’s next, adapting without compromising standards. Since 2014, more than half of all FDA drug approvals came from ERT-supported studies. By identifying trial risks before they become problems, ERT enables customers to bring clinical treatments to patients quickly — and with confidence.
monARC Bionetworks is a healthcare technology company on a mission to modernize the clinical research industry by empowering patients to share their data and participate anytime, anywhere. By allowing patients to directly donate their data, monARC is creating a new data-sharing economy that will transform the highly sequential and siloed drug development model into an integrated and a collaborative model with patients.
With an understanding that development of better medicine begins with better disease models, Xylyx Bio’s native, disease-specific substrates enable cell models that are significantly more predictive of human pathophysiology, allowing drug candidates to be investigated in vitro in a disease-relevant environment. Xylyx products comprise the complex ratios of ECM components specific to each tissue/organ type and disease state and are available in a variety of formats to support high-throughput assays.
Aragen Bioscience is a leading contract research organization, focused on accelerating antibody and other large-molecule pre-clinical development. Our integrated service offerings include: cell line development, protein expression, protein purification, process development, cell-based assays, biophysical assays, and in vivo models of disease. We are based in the San Francisco Bay Area.
Illingworth Research Group's is unique in that we provide two niche services as well as our tailored CRO services. These are on and off-site research nursing and medical photography.
We have an operational team with many years’ experience, in all trial Phases and is across many therapeutic areas but specialise in cough and IPF studies. This paired with our Research Nursing service can lead to patient centric solution within respiratory research.
Polarean supplies products to enable hyperpolarized gas MR imaging research. Hyperpolarized gas MRI offers a fundamentally new, non-invasive means of imaging lung structure and function, which could be used for early diagnosis, more detailed characterization of regional function, and monitoring of progression and therapeutic response. Hyperpolarized inert gases are used to enable 3-dimensional breath-hold imaging of pulmonary physiology and function. With its high speed and resolution, absence of ionizing radiation, and use of inhaled gases that are not metabolized, Polarean’s hyperpolarized MRI technology is inherently non-invasive and suited for repeat use. Polarean's products are currently used by research institutions worldwide, and are sold for research and investigational applications pending FDA approval.
Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies. Since its founding in 1885, the company has remained family-owned and today creates value through innovation for three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. Boehringer Ingelheim is committed to improving lives and providing valuable services and support to patients and their families. Our employees create and engage in programs that strengthen our communities. For more information please visit www.boehringer-ingelheim.us
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 40 years. Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.
Covance Inc., the drug development business of Laboratory Corporation of America Holdings (LabCorp) headquartered in Princeton, New Jersey, USA, is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®. Information on Covance’s solutions can be obtained through its website at covance.com.